NOVO NORDISK A S (NVO)
Clinical trial NCT07157423 updates: 1. completion date: 2027-03-26 → 2027-08-26 2. primary completion date: 2027-03-26 → 2027-08-26
Clinical trial NCT07157423 updates: 1. completion date: 2027-03-26 → 2027-08-26 2. primary completion date: 2027-03-26 → 2027-08-26
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical